Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
16.77
+0.60 (3.71%)
Mar 25, 2025, 4:00 PM EST - Market closed
Mineralys Therapeutics Employees
Mineralys Therapeutics had 51 employees as of December 31, 2024. The number of employees increased by 23 or 82.14% compared to the previous year.
Employees
51
Change (1Y)
23
Growth (1Y)
82.14%
Revenue / Employee
n/a
Profits / Employee
-$3,486,471
Market Cap
836.24M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51 | 23 | 82.14% |
| Dec 31, 2023 | 28 | 16 | 133.33% |
| Dec 31, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MLYS News
- 20 hours ago - Mineralys Therapeutics to Host KOL Call to Discuss Clinical Data from Launch-HTN and Advance-HTN Pivotal Trials Tuesday, April 1, 2025, at 8:00 AM ET - GlobeNewsWire
- 7 days ago - Mineralys Therapeutics Announces Closing of Underwriters' Option to Purchase Additional Shares in Connection with Public Offering of Common Stock - GlobeNewsWire
- 8 days ago - Mineralys Therapeutics Announces Data from the Phase 2 Advance-HTN Trial of Lorundrosat for the Treatment of Hypertension Has Been Accepted as a Late-Breaking Presentation at the 2025 American College of Cardiology's Annual Scientific Session & Expo - GlobeNewsWire
- 13 days ago - Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 14 days ago - Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
- 15 days ago - Mineralys: Prospects Just Got Better With Successful Pivotal Data Readouts - Seeking Alpha
- 15 days ago - Mineralys Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 15 days ago - Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate - Benzinga